nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MTR—hematologic cancer	0.513	1	CbGaD
Hydroxocobalamin—Cyanocobalamin—MTR—hematologic cancer	0.00379	0.745	CrCbGaD
Hydroxocobalamin—MMAA—hematopoietic system—hematologic cancer	0.00337	0.0377	CbGeAlD
Hydroxocobalamin—TCN1—hematopoietic system—hematologic cancer	0.00321	0.0359	CbGeAlD
Hydroxocobalamin—MMAB—hematopoietic system—hematologic cancer	0.00316	0.0354	CbGeAlD
Hydroxocobalamin—MMACHC—lung—hematologic cancer	0.00299	0.0334	CbGeAlD
Hydroxocobalamin—CASP9—hematopoietic system—hematologic cancer	0.00295	0.033	CbGeAlD
Hydroxocobalamin—TCN2—hematopoietic system—hematologic cancer	0.00288	0.0323	CbGeAlD
Hydroxocobalamin—AMN—lung—hematologic cancer	0.00246	0.0275	CbGeAlD
Hydroxocobalamin—AMN—testis—hematologic cancer	0.00232	0.026	CbGeAlD
Hydroxocobalamin—MUT—hematopoietic system—hematologic cancer	0.00227	0.0254	CbGeAlD
Hydroxocobalamin—MMAA—blood—hematologic cancer	0.00223	0.025	CbGeAlD
Hydroxocobalamin—TCN1—blood—hematologic cancer	0.00213	0.0238	CbGeAlD
Hydroxocobalamin—MMAB—blood—hematologic cancer	0.0021	0.0234	CbGeAlD
Hydroxocobalamin—TCN1—bone marrow—hematologic cancer	0.00206	0.023	CbGeAlD
Hydroxocobalamin—MTRR—hematopoietic system—hematologic cancer	0.00204	0.0228	CbGeAlD
Hydroxocobalamin—MMAA—lung—hematologic cancer	0.00196	0.0219	CbGeAlD
Hydroxocobalamin—CASP9—blood—hematologic cancer	0.00196	0.0219	CbGeAlD
Hydroxocobalamin—CUBN—testis—hematologic cancer	0.00195	0.0219	CbGeAlD
Hydroxocobalamin—TCN2—blood—hematologic cancer	0.00191	0.0214	CbGeAlD
Hydroxocobalamin—TCN1—lung—hematologic cancer	0.00186	0.0209	CbGeAlD
Hydroxocobalamin—MMAA—testis—hematologic cancer	0.00185	0.0207	CbGeAlD
Hydroxocobalamin—MMAB—lung—hematologic cancer	0.00184	0.0205	CbGeAlD
Hydroxocobalamin—MTR—hematopoietic system—hematologic cancer	0.00178	0.0199	CbGeAlD
Hydroxocobalamin—MMAB—testis—hematologic cancer	0.00173	0.0194	CbGeAlD
Hydroxocobalamin—MUT—gonad—hematologic cancer	0.00172	0.0193	CbGeAlD
Hydroxocobalamin—CASP9—lung—hematologic cancer	0.00172	0.0192	CbGeAlD
Hydroxocobalamin—AMN—lymph node—hematologic cancer	0.00168	0.0188	CbGeAlD
Hydroxocobalamin—TCN2—lung—hematologic cancer	0.00167	0.0187	CbGeAlD
Hydroxocobalamin—CASP9—testis—hematologic cancer	0.00162	0.0181	CbGeAlD
Hydroxocobalamin—TCN2—testis—hematologic cancer	0.00158	0.0177	CbGeAlD
Hydroxocobalamin—MTRR—gonad—hematologic cancer	0.00155	0.0173	CbGeAlD
Hydroxocobalamin—MUT—blood—hematologic cancer	0.0015	0.0168	CbGeAlD
Hydroxocobalamin—MUT—bone marrow—hematologic cancer	0.00145	0.0163	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—hematologic cancer	0.00142	0.0158	CbGeAlD
Hydroxocobalamin—MTR—gonad—hematologic cancer	0.00135	0.0151	CbGeAlD
Hydroxocobalamin—MTRR—blood—hematologic cancer	0.00135	0.0151	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—hematologic cancer	0.00134	0.015	CbGeAlD
Hydroxocobalamin—MUT—lung—hematologic cancer	0.00132	0.0147	CbGeAlD
Hydroxocobalamin—MTRR—bone marrow—hematologic cancer	0.00131	0.0146	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—MTHFR—hematologic cancer	0.0013	0.255	CrCbGaD
Hydroxocobalamin—MMAB—lymph node—hematologic cancer	0.00126	0.014	CbGeAlD
Hydroxocobalamin—MUT—testis—hematologic cancer	0.00124	0.0139	CbGeAlD
Hydroxocobalamin—MTRR—lung—hematologic cancer	0.00118	0.0132	CbGeAlD
Hydroxocobalamin—MTR—blood—hematologic cancer	0.00118	0.0132	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—hematologic cancer	0.00117	0.0131	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—hematologic cancer	0.00115	0.0128	CbGeAlD
Hydroxocobalamin—MTR—bone marrow—hematologic cancer	0.00114	0.0127	CbGeAlD
Hydroxocobalamin—MTRR—testis—hematologic cancer	0.00112	0.0125	CbGeAlD
Hydroxocobalamin—MTR—lung—hematologic cancer	0.00103	0.0115	CbGeAlD
Hydroxocobalamin—MTR—testis—hematologic cancer	0.000974	0.0109	CbGeAlD
Hydroxocobalamin—MUT—lymph node—hematologic cancer	0.000901	0.0101	CbGeAlD
Hydroxocobalamin—MTRR—lymph node—hematologic cancer	0.000809	0.00905	CbGeAlD
Hydroxocobalamin—MTR—lymph node—hematologic cancer	0.000706	0.0079	CbGeAlD
Hydroxocobalamin—Dermatitis—Thalidomide—hematologic cancer	4.9e-05	0.000243	CcSEcCtD
Hydroxocobalamin—Dizziness—Alitretinoin—hematologic cancer	4.89e-05	0.000242	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vincristine—hematologic cancer	4.87e-05	0.000242	CcSEcCtD
Hydroxocobalamin—Headache—Thalidomide—hematologic cancer	4.87e-05	0.000241	CcSEcCtD
Hydroxocobalamin—Pain—Prednisolone—hematologic cancer	4.87e-05	0.000241	CcSEcCtD
Hydroxocobalamin—Dizziness—Ifosfamide—hematologic cancer	4.83e-05	0.00024	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—hematologic cancer	4.81e-05	0.000238	CcSEcCtD
Hydroxocobalamin—Pruritus—Gemcitabine—hematologic cancer	4.78e-05	0.000237	CcSEcCtD
Hydroxocobalamin—Nausea—Thiotepa—hematologic cancer	4.77e-05	0.000237	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Methotrexate—hematologic cancer	4.77e-05	0.000237	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Etoposide—hematologic cancer	4.76e-05	0.000236	CcSEcCtD
Hydroxocobalamin—Oedema—Betamethasone—hematologic cancer	4.75e-05	0.000236	CcSEcCtD
Hydroxocobalamin—Oedema—Dexamethasone—hematologic cancer	4.75e-05	0.000236	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Dexamethasone—hematologic cancer	4.75e-05	0.000236	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Betamethasone—hematologic cancer	4.75e-05	0.000236	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mitoxantrone—hematologic cancer	4.75e-05	0.000235	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Irinotecan—hematologic cancer	4.75e-05	0.000235	CcSEcCtD
Hydroxocobalamin—Infection—Dexamethasone—hematologic cancer	4.72e-05	0.000234	CcSEcCtD
Hydroxocobalamin—Infection—Betamethasone—hematologic cancer	4.72e-05	0.000234	CcSEcCtD
Hydroxocobalamin—Dizziness—Vincristine—hematologic cancer	4.71e-05	0.000234	CcSEcCtD
Hydroxocobalamin—Rash—Carmustine—hematologic cancer	4.71e-05	0.000233	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Prednisone—hematologic cancer	4.7e-05	0.000233	CcSEcCtD
Hydroxocobalamin—Dermatitis—Carmustine—hematologic cancer	4.7e-05	0.000233	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Prednisolone—hematologic cancer	4.69e-05	0.000233	CcSEcCtD
Hydroxocobalamin—Headache—Carmustine—hematologic cancer	4.68e-05	0.000232	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Triamcinolone—hematologic cancer	4.67e-05	0.000231	CcSEcCtD
Hydroxocobalamin—Rash—Alitretinoin—hematologic cancer	4.66e-05	0.000231	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Dexamethasone—hematologic cancer	4.66e-05	0.000231	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Betamethasone—hematologic cancer	4.66e-05	0.000231	CcSEcCtD
Hydroxocobalamin—Agitation—Prednisone—hematologic cancer	4.66e-05	0.000231	CcSEcCtD
Hydroxocobalamin—Dermatitis—Alitretinoin—hematologic cancer	4.66e-05	0.000231	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Cisplatin—hematologic cancer	4.64e-05	0.00023	CcSEcCtD
Hydroxocobalamin—Tachycardia—Dexamethasone—hematologic cancer	4.64e-05	0.00023	CcSEcCtD
Hydroxocobalamin—Tachycardia—Betamethasone—hematologic cancer	4.64e-05	0.00023	CcSEcCtD
Hydroxocobalamin—Headache—Alitretinoin—hematologic cancer	4.63e-05	0.00023	CcSEcCtD
Hydroxocobalamin—Angioedema—Prednisone—hematologic cancer	4.63e-05	0.00023	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Gemcitabine—hematologic cancer	4.62e-05	0.000229	CcSEcCtD
Hydroxocobalamin—Nausea—Thalidomide—hematologic cancer	4.62e-05	0.000229	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Triamcinolone—hematologic cancer	4.61e-05	0.000229	CcSEcCtD
Hydroxocobalamin—Rash—Ifosfamide—hematologic cancer	4.61e-05	0.000228	CcSEcCtD
Hydroxocobalamin—Dermatitis—Ifosfamide—hematologic cancer	4.6e-05	0.000228	CcSEcCtD
Hydroxocobalamin—Dizziness—Irinotecan—hematologic cancer	4.59e-05	0.000228	CcSEcCtD
Hydroxocobalamin—Urticaria—Etoposide—hematologic cancer	4.59e-05	0.000227	CcSEcCtD
Hydroxocobalamin—Malaise—Prednisone—hematologic cancer	4.57e-05	0.000227	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Etoposide—hematologic cancer	4.56e-05	0.000226	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—hematologic cancer	4.55e-05	0.000226	CcSEcCtD
Hydroxocobalamin—Urticaria—Prednisolone—hematologic cancer	4.52e-05	0.000224	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—hematologic cancer	4.52e-05	0.000224	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—hematologic cancer	4.5e-05	0.000223	CcSEcCtD
Hydroxocobalamin—Rash—Vincristine—hematologic cancer	4.49e-05	0.000223	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vincristine—hematologic cancer	4.49e-05	0.000223	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—hematologic cancer	4.49e-05	0.000222	CcSEcCtD
Hydroxocobalamin—Pain—Triamcinolone—hematologic cancer	4.48e-05	0.000222	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—hematologic cancer	4.46e-05	0.000221	CcSEcCtD
Hydroxocobalamin—Headache—Vincristine—hematologic cancer	4.46e-05	0.000221	CcSEcCtD
Hydroxocobalamin—Nausea—Carmustine—hematologic cancer	4.43e-05	0.00022	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—hematologic cancer	4.41e-05	0.000219	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—hematologic cancer	4.4e-05	0.000218	CcSEcCtD
Hydroxocobalamin—Nausea—Alitretinoin—hematologic cancer	4.39e-05	0.000218	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—hematologic cancer	4.39e-05	0.000217	CcSEcCtD
Hydroxocobalamin—Rash—Irinotecan—hematologic cancer	4.37e-05	0.000217	CcSEcCtD
Hydroxocobalamin—Rash—Mitoxantrone—hematologic cancer	4.37e-05	0.000217	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mitoxantrone—hematologic cancer	4.37e-05	0.000217	CcSEcCtD
Hydroxocobalamin—Dermatitis—Irinotecan—hematologic cancer	4.37e-05	0.000217	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—hematologic cancer	4.37e-05	0.000217	CcSEcCtD
Hydroxocobalamin—Headache—Mitoxantrone—hematologic cancer	4.35e-05	0.000216	CcSEcCtD
Hydroxocobalamin—Headache—Irinotecan—hematologic cancer	4.35e-05	0.000216	CcSEcCtD
Hydroxocobalamin—Nausea—Ifosfamide—hematologic cancer	4.34e-05	0.000215	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Triamcinolone—hematologic cancer	4.31e-05	0.000214	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Cisplatin—hematologic cancer	4.31e-05	0.000214	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.29e-05	0.000213	CcSEcCtD
Hydroxocobalamin—Discomfort—Prednisone—hematologic cancer	4.26e-05	0.000211	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—hematologic cancer	4.26e-05	0.000211	CcSEcCtD
Hydroxocobalamin—Rash—Gemcitabine—hematologic cancer	4.26e-05	0.000211	CcSEcCtD
Hydroxocobalamin—Dermatitis—Gemcitabine—hematologic cancer	4.26e-05	0.000211	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—hematologic cancer	4.26e-05	0.000211	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Etoposide—hematologic cancer	4.25e-05	0.000211	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—hematologic cancer	4.24e-05	0.00021	CcSEcCtD
Hydroxocobalamin—Headache—Gemcitabine—hematologic cancer	4.23e-05	0.00021	CcSEcCtD
Hydroxocobalamin—Nausea—Vincristine—hematologic cancer	4.23e-05	0.00021	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—hematologic cancer	4.23e-05	0.00021	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Prednisolone—hematologic cancer	4.19e-05	0.000208	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Dexamethasone—hematologic cancer	4.18e-05	0.000207	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Betamethasone—hematologic cancer	4.18e-05	0.000207	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—hematologic cancer	4.16e-05	0.000206	CcSEcCtD
Hydroxocobalamin—Urticaria—Triamcinolone—hematologic cancer	4.16e-05	0.000206	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—hematologic cancer	4.15e-05	0.000206	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Triamcinolone—hematologic cancer	4.14e-05	0.000205	CcSEcCtD
Hydroxocobalamin—Oedema—Prednisone—hematologic cancer	4.14e-05	0.000205	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Prednisone—hematologic cancer	4.14e-05	0.000205	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—hematologic cancer	4.13e-05	0.000205	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—hematologic cancer	4.13e-05	0.000205	CcSEcCtD
Hydroxocobalamin—Nausea—Irinotecan—hematologic cancer	4.12e-05	0.000204	CcSEcCtD
Hydroxocobalamin—Nausea—Mitoxantrone—hematologic cancer	4.12e-05	0.000204	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—hematologic cancer	4.11e-05	0.000204	CcSEcCtD
Hydroxocobalamin—Infection—Prednisone—hematologic cancer	4.11e-05	0.000204	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—hematologic cancer	4.1e-05	0.000204	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.1e-05	0.000203	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.1e-05	0.000203	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—hematologic cancer	4.09e-05	0.000203	CcSEcCtD
Hydroxocobalamin—Pruritus—Etoposide—hematologic cancer	4.08e-05	0.000202	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—hematologic cancer	4.07e-05	0.000202	CcSEcCtD
Hydroxocobalamin—Pain—Dexamethasone—hematologic cancer	4.06e-05	0.000201	CcSEcCtD
Hydroxocobalamin—Pain—Betamethasone—hematologic cancer	4.06e-05	0.000201	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Prednisone—hematologic cancer	4.06e-05	0.000201	CcSEcCtD
Hydroxocobalamin—Tachycardia—Prednisone—hematologic cancer	4.04e-05	0.0002	CcSEcCtD
Hydroxocobalamin—Skin disorder—Prednisone—hematologic cancer	4.02e-05	0.000199	CcSEcCtD
Hydroxocobalamin—Nausea—Gemcitabine—hematologic cancer	4.01e-05	0.000199	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—hematologic cancer	3.99e-05	0.000198	CcSEcCtD
Hydroxocobalamin—Rash—Cisplatin—hematologic cancer	3.97e-05	0.000197	CcSEcCtD
Hydroxocobalamin—Dermatitis—Cisplatin—hematologic cancer	3.97e-05	0.000197	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—hematologic cancer	3.96e-05	0.000197	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Etoposide—hematologic cancer	3.95e-05	0.000196	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—hematologic cancer	3.94e-05	0.000195	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—hematologic cancer	3.93e-05	0.000195	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Betamethasone—hematologic cancer	3.91e-05	0.000194	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dexamethasone—hematologic cancer	3.91e-05	0.000194	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—hematologic cancer	3.91e-05	0.000194	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Triamcinolone—hematologic cancer	3.86e-05	0.000191	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—hematologic cancer	3.82e-05	0.00019	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—hematologic cancer	3.82e-05	0.000189	CcSEcCtD
Hydroxocobalamin—Dizziness—Etoposide—hematologic cancer	3.82e-05	0.000189	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—hematologic cancer	3.81e-05	0.000189	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—hematologic cancer	3.8e-05	0.000188	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—hematologic cancer	3.78e-05	0.000187	CcSEcCtD
Hydroxocobalamin—Urticaria—Betamethasone—hematologic cancer	3.77e-05	0.000187	CcSEcCtD
Hydroxocobalamin—Urticaria—Dexamethasone—hematologic cancer	3.77e-05	0.000187	CcSEcCtD
Hydroxocobalamin—Dizziness—Prednisolone—hematologic cancer	3.76e-05	0.000187	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—hematologic cancer	3.76e-05	0.000187	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Betamethasone—hematologic cancer	3.75e-05	0.000186	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dexamethasone—hematologic cancer	3.75e-05	0.000186	CcSEcCtD
Hydroxocobalamin—Nausea—Cisplatin—hematologic cancer	3.74e-05	0.000186	CcSEcCtD
Hydroxocobalamin—Pruritus—Triamcinolone—hematologic cancer	3.7e-05	0.000184	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—hematologic cancer	3.69e-05	0.000183	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—hematologic cancer	3.68e-05	0.000182	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—hematologic cancer	3.67e-05	0.000182	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—hematologic cancer	3.64e-05	0.000181	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Prednisone—hematologic cancer	3.64e-05	0.000181	CcSEcCtD
Hydroxocobalamin—Rash—Etoposide—hematologic cancer	3.64e-05	0.00018	CcSEcCtD
Hydroxocobalamin—Dermatitis—Etoposide—hematologic cancer	3.64e-05	0.00018	CcSEcCtD
Hydroxocobalamin—Headache—Etoposide—hematologic cancer	3.62e-05	0.000179	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—hematologic cancer	3.61e-05	0.000179	CcSEcCtD
Hydroxocobalamin—Rash—Prednisolone—hematologic cancer	3.59e-05	0.000178	CcSEcCtD
Hydroxocobalamin—Dermatitis—Prednisolone—hematologic cancer	3.59e-05	0.000178	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.58e-05	0.000178	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—hematologic cancer	3.57e-05	0.000177	CcSEcCtD
Hydroxocobalamin—Headache—Prednisolone—hematologic cancer	3.57e-05	0.000177	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—hematologic cancer	3.56e-05	0.000177	CcSEcCtD
Hydroxocobalamin—Dizziness—Triamcinolone—hematologic cancer	3.46e-05	0.000172	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—hematologic cancer	3.46e-05	0.000171	CcSEcCtD
Hydroxocobalamin—Infection—Methotrexate—hematologic cancer	3.43e-05	0.00017	CcSEcCtD
Hydroxocobalamin—Nausea—Etoposide—hematologic cancer	3.43e-05	0.00017	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Prednisone—hematologic cancer	3.41e-05	0.000169	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—hematologic cancer	3.4e-05	0.000169	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—hematologic cancer	3.39e-05	0.000168	CcSEcCtD
Hydroxocobalamin—Nausea—Prednisolone—hematologic cancer	3.38e-05	0.000168	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—hematologic cancer	3.37e-05	0.000167	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—hematologic cancer	3.37e-05	0.000167	CcSEcCtD
Hydroxocobalamin—Pruritus—Dexamethasone—hematologic cancer	3.36e-05	0.000167	CcSEcCtD
Hydroxocobalamin—Pruritus—Betamethasone—hematologic cancer	3.36e-05	0.000167	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—hematologic cancer	3.36e-05	0.000167	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.35e-05	0.000166	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—hematologic cancer	3.33e-05	0.000165	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—hematologic cancer	3.31e-05	0.000164	CcSEcCtD
Hydroxocobalamin—Rash—Triamcinolone—hematologic cancer	3.3e-05	0.000164	CcSEcCtD
Hydroxocobalamin—Dermatitis—Triamcinolone—hematologic cancer	3.3e-05	0.000164	CcSEcCtD
Hydroxocobalamin—Urticaria—Prednisone—hematologic cancer	3.29e-05	0.000163	CcSEcCtD
Hydroxocobalamin—Headache—Triamcinolone—hematologic cancer	3.28e-05	0.000163	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Prednisone—hematologic cancer	3.27e-05	0.000162	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dexamethasone—hematologic cancer	3.25e-05	0.000161	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Betamethasone—hematologic cancer	3.25e-05	0.000161	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—hematologic cancer	3.24e-05	0.00016	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—hematologic cancer	3.24e-05	0.00016	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—hematologic cancer	3.21e-05	0.000159	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—hematologic cancer	3.17e-05	0.000157	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—hematologic cancer	3.16e-05	0.000157	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—hematologic cancer	3.14e-05	0.000156	CcSEcCtD
Hydroxocobalamin—Dizziness—Dexamethasone—hematologic cancer	3.14e-05	0.000156	CcSEcCtD
Hydroxocobalamin—Dizziness—Betamethasone—hematologic cancer	3.14e-05	0.000156	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—hematologic cancer	3.12e-05	0.000155	CcSEcCtD
Hydroxocobalamin—Nausea—Triamcinolone—hematologic cancer	3.11e-05	0.000154	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.1e-05	0.000154	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—hematologic cancer	3.09e-05	0.000153	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Methotrexate—hematologic cancer	3.08e-05	0.000153	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Prednisone—hematologic cancer	3.05e-05	0.000151	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Methotrexate—hematologic cancer	3.04e-05	0.000151	CcSEcCtD
Hydroxocobalamin—Rash—Betamethasone—hematologic cancer	2.99e-05	0.000149	CcSEcCtD
Hydroxocobalamin—Rash—Dexamethasone—hematologic cancer	2.99e-05	0.000149	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.99e-05	0.000148	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—hematologic cancer	2.99e-05	0.000148	CcSEcCtD
Hydroxocobalamin—Dermatitis—Dexamethasone—hematologic cancer	2.99e-05	0.000148	CcSEcCtD
Hydroxocobalamin—Dermatitis—Betamethasone—hematologic cancer	2.99e-05	0.000148	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.98e-05	0.000148	CcSEcCtD
Hydroxocobalamin—Headache—Betamethasone—hematologic cancer	2.98e-05	0.000148	CcSEcCtD
Hydroxocobalamin—Headache—Dexamethasone—hematologic cancer	2.98e-05	0.000148	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—hematologic cancer	2.97e-05	0.000147	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—hematologic cancer	2.96e-05	0.000147	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—hematologic cancer	2.94e-05	0.000146	CcSEcCtD
Hydroxocobalamin—Pruritus—Prednisone—hematologic cancer	2.93e-05	0.000145	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—hematologic cancer	2.92e-05	0.000145	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—hematologic cancer	2.91e-05	0.000144	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—hematologic cancer	2.88e-05	0.000143	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methotrexate—hematologic cancer	2.85e-05	0.000141	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—hematologic cancer	2.85e-05	0.000141	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Prednisone—hematologic cancer	2.83e-05	0.00014	CcSEcCtD
Hydroxocobalamin—Nausea—Dexamethasone—hematologic cancer	2.82e-05	0.00014	CcSEcCtD
Hydroxocobalamin—Nausea—Betamethasone—hematologic cancer	2.82e-05	0.00014	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.79e-05	0.000139	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—hematologic cancer	2.77e-05	0.000137	CcSEcCtD
Hydroxocobalamin—Urticaria—Methotrexate—hematologic cancer	2.75e-05	0.000136	CcSEcCtD
Hydroxocobalamin—Dizziness—Prednisone—hematologic cancer	2.74e-05	0.000136	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—hematologic cancer	2.73e-05	0.000136	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—hematologic cancer	2.67e-05	0.000132	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—hematologic cancer	2.67e-05	0.000132	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—hematologic cancer	2.64e-05	0.000131	CcSEcCtD
Hydroxocobalamin—Rash—Prednisone—hematologic cancer	2.61e-05	0.000129	CcSEcCtD
Hydroxocobalamin—Dermatitis—Prednisone—hematologic cancer	2.61e-05	0.000129	CcSEcCtD
Hydroxocobalamin—Headache—Prednisone—hematologic cancer	2.59e-05	0.000129	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.58e-05	0.000128	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—hematologic cancer	2.57e-05	0.000127	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—hematologic cancer	2.56e-05	0.000127	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—hematologic cancer	2.56e-05	0.000127	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methotrexate—hematologic cancer	2.55e-05	0.000126	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—hematologic cancer	2.47e-05	0.000122	CcSEcCtD
Hydroxocobalamin—Nausea—Prednisone—hematologic cancer	2.46e-05	0.000122	CcSEcCtD
Hydroxocobalamin—Pruritus—Methotrexate—hematologic cancer	2.45e-05	0.000121	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—hematologic cancer	2.38e-05	0.000118	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—hematologic cancer	2.38e-05	0.000118	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—hematologic cancer	2.37e-05	0.000117	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—hematologic cancer	2.37e-05	0.000117	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—hematologic cancer	2.29e-05	0.000114	CcSEcCtD
Hydroxocobalamin—Dizziness—Methotrexate—hematologic cancer	2.29e-05	0.000113	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—hematologic cancer	2.21e-05	0.00011	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—hematologic cancer	2.21e-05	0.000109	CcSEcCtD
Hydroxocobalamin—Rash—Methotrexate—hematologic cancer	2.18e-05	0.000108	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—hematologic cancer	2.18e-05	0.000108	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—hematologic cancer	2.17e-05	0.000107	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—hematologic cancer	2.14e-05	0.000106	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—hematologic cancer	2.12e-05	0.000105	CcSEcCtD
Hydroxocobalamin—Nausea—Methotrexate—hematologic cancer	2.05e-05	0.000102	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—hematologic cancer	2.05e-05	0.000102	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—hematologic cancer	2.04e-05	0.000101	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—hematologic cancer	2.04e-05	0.000101	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—hematologic cancer	2.03e-05	0.000101	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—hematologic cancer	1.98e-05	9.82e-05	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—hematologic cancer	1.92e-05	9.53e-05	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—hematologic cancer	1.89e-05	9.36e-05	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—hematologic cancer	1.89e-05	9.35e-05	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—hematologic cancer	1.88e-05	9.3e-05	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—hematologic cancer	1.78e-05	8.82e-05	CcSEcCtD
Hydroxocobalamin—MTRR—Metabolism—PIK3R1—hematologic cancer	6.06e-06	3.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TSC2—hematologic cancer	6.06e-06	3.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ICAM1—hematologic cancer	6.03e-06	3.16e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—hematologic cancer	6.02e-06	3.15e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—hematologic cancer	6.02e-06	3.15e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK3—hematologic cancer	6e-06	3.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BAD—hematologic cancer	5.98e-06	3.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NFKBIA—hematologic cancer	5.98e-06	3.14e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGF2—hematologic cancer	5.98e-06	3.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT1—hematologic cancer	5.97e-06	3.13e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—hematologic cancer	5.95e-06	3.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3R1—hematologic cancer	5.9e-06	3.09e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—hematologic cancer	5.88e-06	3.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—hematologic cancer	5.87e-06	3.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SRC—hematologic cancer	5.86e-06	3.07e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—hematologic cancer	5.85e-06	3.07e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—hematologic cancer	5.84e-06	3.06e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—hematologic cancer	5.84e-06	3.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGFR3—hematologic cancer	5.82e-06	3.05e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—hematologic cancer	5.82e-06	3.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD80—hematologic cancer	5.8e-06	3.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—hematologic cancer	5.79e-06	3.04e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1A—hematologic cancer	5.78e-06	3.03e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—hematologic cancer	5.77e-06	3.03e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—JAK2—hematologic cancer	5.73e-06	3.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTPN11—hematologic cancer	5.69e-06	2.98e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—hematologic cancer	5.69e-06	2.98e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—hematologic cancer	5.69e-06	2.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—hematologic cancer	5.64e-06	2.96e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—hematologic cancer	5.63e-06	2.95e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—hematologic cancer	5.63e-06	2.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK3—hematologic cancer	5.63e-06	2.95e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—EP300—hematologic cancer	5.61e-06	2.94e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MDM2—hematologic cancer	5.59e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—hematologic cancer	5.59e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CB—hematologic cancer	5.59e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GRB2—hematologic cancer	5.58e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFA—hematologic cancer	5.57e-06	2.92e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—hematologic cancer	5.55e-06	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—hematologic cancer	5.55e-06	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FOS—hematologic cancer	5.52e-06	2.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BAD—hematologic cancer	5.52e-06	2.9e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CREBBP—hematologic cancer	5.52e-06	2.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CREB1—hematologic cancer	5.51e-06	2.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EP300—hematologic cancer	5.5e-06	2.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KITLG—hematologic cancer	5.49e-06	2.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOTCH1—hematologic cancer	5.47e-06	2.87e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTOR—hematologic cancer	5.44e-06	2.85e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CB—hematologic cancer	5.44e-06	2.85e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD4—hematologic cancer	5.43e-06	2.85e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—hematologic cancer	5.4e-06	2.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CASP8—hematologic cancer	5.39e-06	2.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6R—hematologic cancer	5.38e-06	2.82e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—hematologic cancer	5.37e-06	2.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CREBBP—hematologic cancer	5.37e-06	2.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT5A—hematologic cancer	5.36e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD80—hematologic cancer	5.36e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SRC—hematologic cancer	5.35e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—hematologic cancer	5.35e-06	2.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN2B—hematologic cancer	5.32e-06	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—hematologic cancer	5.29e-06	2.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTPN11—hematologic cancer	5.25e-06	2.76e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CD—hematologic cancer	5.23e-06	2.74e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—hematologic cancer	5.21e-06	2.73e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—hematologic cancer	5.21e-06	2.73e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ALB—hematologic cancer	5.16e-06	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—hematologic cancer	5.16e-06	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—hematologic cancer	5.16e-06	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—hematologic cancer	5.15e-06	2.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CD86—hematologic cancer	5.14e-06	2.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAP2K1—hematologic cancer	5.13e-06	2.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1B—hematologic cancer	5.11e-06	2.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CD—hematologic cancer	5.09e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CREB1—hematologic cancer	5.09e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—hematologic cancer	5.08e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HES1—hematologic cancer	5.07e-06	2.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—hematologic cancer	5.06e-06	2.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NCOR1—hematologic cancer	5.04e-06	2.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—hematologic cancer	5.03e-06	2.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CSF2—hematologic cancer	4.99e-06	2.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF1—hematologic cancer	4.99e-06	2.62e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—hematologic cancer	4.99e-06	2.61e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—hematologic cancer	4.99e-06	2.61e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—hematologic cancer	4.97e-06	2.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6R—hematologic cancer	4.97e-06	2.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CREBBP—hematologic cancer	4.96e-06	2.6e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—hematologic cancer	4.96e-06	2.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3R1—hematologic cancer	4.94e-06	2.59e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK3—hematologic cancer	4.93e-06	2.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FOXO1—hematologic cancer	4.92e-06	2.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFRB—hematologic cancer	4.91e-06	2.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGF2—hematologic cancer	4.88e-06	2.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—hematologic cancer	4.86e-06	2.55e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—hematologic cancer	4.83e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFRA—hematologic cancer	4.83e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JAK1—hematologic cancer	4.81e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRKCG—hematologic cancer	4.81e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3R1—hematologic cancer	4.81e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—hematologic cancer	4.79e-06	2.51e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—hematologic cancer	4.78e-06	2.51e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—hematologic cancer	4.76e-06	2.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAP2K1—hematologic cancer	4.73e-06	2.48e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—hematologic cancer	4.71e-06	2.47e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—hematologic cancer	4.71e-06	2.47e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1A—hematologic cancer	4.71e-06	2.47e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—hematologic cancer	4.7e-06	2.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CD—hematologic cancer	4.7e-06	2.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JAK2—hematologic cancer	4.67e-06	2.45e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—hematologic cancer	4.65e-06	2.44e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—hematologic cancer	4.65e-06	2.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—hematologic cancer	4.65e-06	2.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—hematologic cancer	4.63e-06	2.43e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—EP300—hematologic cancer	4.61e-06	2.42e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—hematologic cancer	4.6e-06	2.41e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—hematologic cancer	4.6e-06	2.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNG—hematologic cancer	4.59e-06	2.41e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—hematologic cancer	4.59e-06	2.4e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MDM2—hematologic cancer	4.56e-06	2.39e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CB—hematologic cancer	4.56e-06	2.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGF2—hematologic cancer	4.5e-06	2.36e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—hematologic cancer	4.5e-06	2.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2RA—hematologic cancer	4.5e-06	2.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EP300—hematologic cancer	4.49e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—hematologic cancer	4.46e-06	2.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—hematologic cancer	4.44e-06	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3R1—hematologic cancer	4.44e-06	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CB—hematologic cancer	4.44e-06	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MTOR—hematologic cancer	4.44e-06	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—hematologic cancer	4.43e-06	2.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD4—hematologic cancer	4.43e-06	2.32e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—hematologic cancer	4.39e-06	2.3e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—hematologic cancer	4.39e-06	2.3e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SRC—hematologic cancer	4.36e-06	2.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFB—hematologic cancer	4.34e-06	2.28e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—hematologic cancer	4.32e-06	2.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—JAK2—hematologic cancer	4.31e-06	2.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—hematologic cancer	4.3e-06	2.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSC2—hematologic cancer	4.24e-06	2.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MDM2—hematologic cancer	4.21e-06	2.21e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—hematologic cancer	4.21e-06	2.21e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—hematologic cancer	4.2e-06	2.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1B—hematologic cancer	4.17e-06	2.18e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—hematologic cancer	4.15e-06	2.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—hematologic cancer	4.13e-06	2.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—hematologic cancer	4.11e-06	2.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CB—hematologic cancer	4.1e-06	2.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTOR—hematologic cancer	4.1e-06	2.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL1B—hematologic cancer	4.09e-06	2.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD4—hematologic cancer	4.09e-06	2.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR3—hematologic cancer	4.08e-06	2.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—hematologic cancer	4.08e-06	2.14e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—hematologic cancer	4.07e-06	2.13e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—hematologic cancer	4.05e-06	2.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK14—hematologic cancer	4.04e-06	2.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK3—hematologic cancer	4.02e-06	2.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JUN—hematologic cancer	3.97e-06	2.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ESR1—hematologic cancer	3.96e-06	2.08e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—hematologic cancer	3.94e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FN1—hematologic cancer	3.91e-06	2.05e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—hematologic cancer	3.91e-06	2.05e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—hematologic cancer	3.9e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BAD—hematologic cancer	3.87e-06	2.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NFKBIA—hematologic cancer	3.87e-06	2.03e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—hematologic cancer	3.85e-06	2.02e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—hematologic cancer	3.85e-06	2.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1B—hematologic cancer	3.85e-06	2.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1A—hematologic cancer	3.84e-06	2.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—hematologic cancer	3.84e-06	2.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH1—hematologic cancer	3.83e-06	2.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—hematologic cancer	3.79e-06	1.99e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—hematologic cancer	3.77e-06	1.97e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—EP300—hematologic cancer	3.76e-06	1.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK8—hematologic cancer	3.75e-06	1.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CD80—hematologic cancer	3.75e-06	1.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—hematologic cancer	3.75e-06	1.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—hematologic cancer	3.75e-06	1.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTPN11—hematologic cancer	3.68e-06	1.93e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—hematologic cancer	3.67e-06	1.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EP300—hematologic cancer	3.66e-06	1.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—hematologic cancer	3.64e-06	1.91e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—hematologic cancer	3.61e-06	1.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—hematologic cancer	3.6e-06	1.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CREB1—hematologic cancer	3.56e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SRC—hematologic cancer	3.56e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1A—hematologic cancer	3.55e-06	1.86e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—hematologic cancer	3.54e-06	1.86e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—hematologic cancer	3.52e-06	1.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL2—hematologic cancer	3.49e-06	1.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6R—hematologic cancer	3.48e-06	1.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CREBBP—hematologic cancer	3.47e-06	1.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—hematologic cancer	3.43e-06	1.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—hematologic cancer	3.42e-06	1.79e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—hematologic cancer	3.41e-06	1.79e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—hematologic cancer	3.39e-06	1.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EP300—hematologic cancer	3.38e-06	1.77e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—hematologic cancer	3.33e-06	1.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—hematologic cancer	3.32e-06	1.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAP2K1—hematologic cancer	3.31e-06	1.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CD—hematologic cancer	3.29e-06	1.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SRC—hematologic cancer	3.28e-06	1.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK3—hematologic cancer	3.28e-06	1.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—hematologic cancer	3.17e-06	1.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—hematologic cancer	3.16e-06	1.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF2—hematologic cancer	3.15e-06	1.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3R1—hematologic cancer	3.11e-06	1.63e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—hematologic cancer	3.07e-06	1.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK3—hematologic cancer	3.03e-06	1.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JAK2—hematologic cancer	3.02e-06	1.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MDM2—hematologic cancer	2.95e-06	1.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—hematologic cancer	2.95e-06	1.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—hematologic cancer	2.94e-06	1.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—hematologic cancer	2.94e-06	1.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—hematologic cancer	2.94e-06	1.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MTOR—hematologic cancer	2.87e-06	1.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CB—hematologic cancer	2.87e-06	1.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—hematologic cancer	2.78e-06	1.46e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—hematologic cancer	2.78e-06	1.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—hematologic cancer	2.72e-06	1.43e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—hematologic cancer	2.71e-06	1.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—hematologic cancer	2.71e-06	1.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1B—hematologic cancer	2.69e-06	1.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—hematologic cancer	2.64e-06	1.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—hematologic cancer	2.64e-06	1.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—hematologic cancer	2.57e-06	1.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JUN—hematologic cancer	2.56e-06	1.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—hematologic cancer	2.5e-06	1.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—hematologic cancer	2.5e-06	1.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1A—hematologic cancer	2.49e-06	1.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—hematologic cancer	2.48e-06	1.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK8—hematologic cancer	2.43e-06	1.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—hematologic cancer	2.4e-06	1.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EP300—hematologic cancer	2.36e-06	1.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—hematologic cancer	2.31e-06	1.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SRC—hematologic cancer	2.3e-06	1.21e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—hematologic cancer	2.27e-06	1.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—hematologic cancer	2.24e-06	1.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—hematologic cancer	2.22e-06	1.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—hematologic cancer	2.21e-06	1.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—hematologic cancer	2.21e-06	1.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—hematologic cancer	2.21e-06	1.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK3—hematologic cancer	2.12e-06	1.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—hematologic cancer	2.06e-06	1.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—hematologic cancer	2.06e-06	1.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—hematologic cancer	2.04e-06	1.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—hematologic cancer	1.9e-06	9.98e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—hematologic cancer	1.75e-06	9.17e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—hematologic cancer	1.69e-06	8.87e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—hematologic cancer	1.62e-06	8.49e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—hematologic cancer	1.55e-06	8.12e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—hematologic cancer	1.43e-06	7.49e-06	CbGpPWpGaD
